{"id":164090,"date":"2025-08-21T15:27:19","date_gmt":"2025-08-21T15:27:19","guid":{"rendered":"https:\/\/www.europesays.com\/us\/164090\/"},"modified":"2025-08-21T15:27:19","modified_gmt":"2025-08-21T15:27:19","slug":"glp-1-drugs-and-vision-loss-how-significant-are-the-risks-medical-news-today","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/164090\/","title":{"rendered":"GLP-1 drugs and vision loss: How significant are the risks? – Medical News Today"},"content":{"rendered":"
    \n
  1. GLP-1 drugs and vision loss: How significant are the risks?<\/a>  Medical News Today<\/li>\n
  2. From stomach paralysis to vision loss: Ozempic faces over $2 bn lawsuits<\/a>  Business Standard<\/li>\n
  3. Ozempic faces $2 billion lawsuits as patients report stomach paralysis, vision loss | Explainer<\/a>  financialexpress.com<\/li>\n
  4. Ozempic reportedly faces $2 billion in lawsuits over severe side effects<\/a>  yahoo.com<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"GLP-1 drugs and vision loss: How significant are the risks?  Medical News Today From stomach paralysis to vision loss:…\n","protected":false},"author":3,"featured_media":164091,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[3654,210,1060,94676,427,15209,67,132,68],"class_list":{"0":"post-164090","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-glp-1","9":"tag-health","10":"tag-medication","11":"tag-naion","12":"tag-ozempic","13":"tag-semaglutide","14":"tag-united-states","15":"tag-unitedstates","16":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115067462835284096","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/164090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=164090"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/164090\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/164091"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=164090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=164090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=164090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}